» Articles » PMID: 17317656

Transforming Growth Factor-beta Receptor Type I-dependent Fibrogenic Gene Program is Mediated Via Activation of Smad1 and ERK1/2 Pathways

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2007 Feb 24
PMID 17317656
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

The transforming growth factor (TGF)-beta/Smad3 signaling pathway is considered a central mediator of pathological organ fibrosis; however, contribution of Smad2/3-independent TGF-beta signaling has not been fully explored. The present study utilized previously a described model of scleroderma (SSc) fibrosis based on forced expression of the TGF-betaRI (ALK5) (Pannu, J., Gardner, H., Shearstone, J. R., Smith, E., and Trojanowska, M. (2006) Arthritis Rheum. 54, 3011-3021). This study was aimed at determining the molecular mechanisms underlying the profibrotic program in this model. We demonstrate that the TGF-betaRI-dependent up-regulation of collagen and CCN2 (CTGF) does not involve Smad2/3 activation but is mediated by ALK1/Smad1 and ERK1/2 pathways. The following findings support this conclusion: (i) Smad2 and -3 were not phosphorylated in response to TGF-betaRI, (ii) a TGF-betaRI mutant defective in Smad2/3 activation, ALK5(3A), potently stimulated collagen production, (iii) elevation of TGF-betaRI triggered sustained association of ALK5 with ALK1 and high levels of Smad1 phosphorylation, (iv) blockade of Smad1 via small interfering RNA abrogated collagen and CCN2 up-regulation in this model, (v) elevated TGF-betaRI led to a prolonged activation of ERK1/2, (vi) the pharmacologic inhibitor of ERK1/2 inhibited Smad1 phosphorylation and abrogated profibrotic effects of elevated TGFbeta-RI. Additional experiments demonstrated that a GC-rich response element located -6 to -16 (upstream of the transcription start site) in the CCN2 promoter mediated Smad1-dependent increased promoter activity in this model. This element was shown previously to mediate up-regulation of the CCN2 promoter in SSc fibroblasts. In conclusion, this study defines a novel ALK1/Smad1- and ERK1/2-dependent, Smad3-independent mode of TGF-beta signaling that may operate during chronic stages of fibrosis in SSc.

Citing Articles

Unraveling the role of MiR-181 in skin fibrosis pathogenesis by targeting NUDT21.

Mills T, Wu M, Alonso J, Puente H, Charles J, Chen Z FASEB J. 2024; 38(17):e70022.

PMID: 39250282 PMC: 11512580. DOI: 10.1096/fj.202400829R.


Fibrotic pathways and fibroblast-like synoviocyte phenotypes in osteoarthritis.

Damerau A, Rosenow E, Alkhoury D, Buttgereit F, Gaber T Front Immunol. 2024; 15:1385006.

PMID: 38895122 PMC: 11183113. DOI: 10.3389/fimmu.2024.1385006.


TGF-β signaling in health, disease, and therapeutics.

Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C Signal Transduct Target Ther. 2024; 9(1):61.

PMID: 38514615 PMC: 10958066. DOI: 10.1038/s41392-024-01764-w.


The Role of Autophagy and Apoptosis in Affected Skin and Lungs in Patients with Systemic Sclerosis.

Spasovski V, Andjelkovic M, Parezanovic M, Komazec J, Ugrin M, Klaassen K Int J Mol Sci. 2023; 24(13).

PMID: 37446389 PMC: 10342863. DOI: 10.3390/ijms241311212.


Cell Sources for Retinal Regeneration: Implication for Data Translation in Biomedicine of the Eye.

Grigoryan E Cells. 2022; 11(23).

PMID: 36497013 PMC: 9738527. DOI: 10.3390/cells11233755.